Jim Cramer is Confident "Someone Will Want Some of Kenvue"

Kenvue Inc. (NYSE:KVUE) is one of the stocks on Jim Cramer’s radar. During the episode, Cramer discussed the company’s recent management change. He remarked:

“Consider Kenvue. Two years ago, this company was spun off by Johnson & Johnson, which just wanted to unload its fantastic consumer business… The company picked this fellow, Thibaut Mongon, and he’s the leader of, he was the leader of J&J’s Consumer Health division… We learned today that he was sacked after activist pressure, and Kirk Perry, a current director, was named interim CEO. Kenvue also announced a strategic review… That’s what we’re hoping will happen at Kraft Heinz.

Is this shocking? Was it amazing that Kenvue already got rid of the CEO in two years? Well, yes, if you saw the numbers. Kenvue reported minus 4% organic growth, and Wall Street was expecting plus 2 to 4%. But I bring this up because more deals are coming in that space… I’m extremely confident that someone will want some of Kenvue, if not all of Kenvue, because those brands grow slowly, but if you put a bunch of them together, you might have something that Wall Street gets very excited about.”

Kenvue Inc. (NYSE:KVUE) develops and markets consumer health products across self-care, skin health, and essential health categories.

While we acknowledge the potential of KVUE as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock.

READ NEXT: 30 Stocks That Should Double in 3 Years and 11 Hidden AI Stocks to Buy Right Now.

Disclosure: None. This article is originally published at Insider Monkey.